Condition 1: chronic cough. Condition 2: Lophomonas Blattarum. Cough
Conditions
Interventions
Intervention 1: Intervention group:Tinidazole 500mg in form of tablet, one each 12 hours, for14 days. The Active Pharmaceutical Ingredient is provided by Pars daru Pharmaceutical company. Intervention
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: patients suffering from more than one months cough who could not be controlled by past medical treatments patients with normal physical examination patients with normal chest-x-ray
Exclusion criteria
Exclusion criteria: drug allergy proven asthma Tuberculosis(TB), gastroesophageal reflux(GERD) , ear wax, Chronic Obstructive Pulmonary disease(COPD), Carcinoma,hemoptesis Angiotensin converting enzyme inhibitors(ACEI) users
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lophomonas Blattarum being in smear or Bronchoalveolarlavage. Timepoint: Before intervention and 14 days after intervention. Method of measurement: Trichrome staining.;Chronic cough grading. Timepoint: Before intervention and 14 days after intervention. Method of measurement: Global Initiative for Asthma (GINA) guideline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dyspnea. Timepoint: Before intervention and 14days after intervention. Method of measurement: physical examination.;Sputum inflammatory cells. Timepoint: Before intervention and 14days after intervention. Method of measurement: sputum cytology.;Dyspnea garding. Timepoint: Before intervention and 14 days after intervention. Method of measurement: GINA(global strategy for asthma).;Body temperature. Timepoint: Before intervention and 14days after intervention. Method of measurement: Thermometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Mirsadraee
Islamic Azad University
Outcome results
None listed